1. Home
  2. AL vs KRYS Comparison

AL vs KRYS Comparison

Compare AL & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Lease Corporation

AL

Air Lease Corporation

HOLD

Current Price

$64.07

Market Cap

7.2B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$244.20

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AL
KRYS
Founded
2010
2015
Country
United States
United States
Employees
165
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.3B
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
AL
KRYS
Price
$64.07
$244.20
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$60.50
$214.22
AVG Volume (30 Days)
2.2M
286.6K
Earning Date
11-03-2025
11-03-2025
Dividend Yield
1.37%
N/A
EPS Growth
96.53
275.72
EPS
8.62
6.66
Revenue
$2,908,265,000.00
$373,164,000.00
Revenue This Year
$10.26
$36.14
Revenue Next Year
$6.10
$41.80
P/E Ratio
$7.43
$36.72
Revenue Growth
6.25
54.51
52 Week Low
$38.25
$122.80
52 Week High
$64.30
$248.60

Technical Indicators

Market Signals
Indicator
AL
KRYS
Relative Strength Index (RSI) 61.81 81.72
Support Level $63.93 $213.83
Resistance Level $64.16 $241.65
Average True Range (ATR) 0.15 7.53
MACD -0.00 2.17
Stochastic Oscillator 70.45 89.34

Price Performance

Historical Comparison
AL
KRYS

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in purchasing commercial jet aircrafts directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a majority of its revenue from the Asia-Pacific region and the rest from Europe, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: